1Witter RL..Influence of serotype and virus strain on synergism among Marek's disease vaccine viruses[J].Avian Pathol,1992,21:601 -614.
2Benton WI.,Cover MS..The increased incidence of visceral lymphornatosis in broiler and replacement birds[J].Avain Dis,1957,1:320- 327.
3Churchill AE.,Payne LN.,Chubb RC..Immunization against Marek's disease using a live attenuated virus[J].Nature,1969,221:744 - 747.
4Witter RL.,Nazerian K.,Purchase HG.,et al.Isolation from turkeys of a cell-associated herpesvirus ani; igenically related to Marek's disease virus[J].Amer J Vet Res,1970,31:525 - 538.
5Schat KA.,Calnek BW.,Fabricant J..Characterization of two highly oncogenic strains of Marek's disease virus[J].Avian Pathol,1985,14:593 - 605.
6Witter RL..Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek's disease virus[J].Avian Pathol,1982,11:49-62.
7Witter RL..Increased virulence of Marek's disease virus field isolates[J].Avian Dis,1997,41:149 - 163.
8Rispens BH.,Van Vloten J.,Mastenbroek N.,et al.Control of Marek's disease in theNetherlands.Ⅱ.Field trails on vaccination with an avirulent strain (CVI988) of Marek's disease virus[J].Avian Dis.,1972,16:126-138.
9Witter RL..Safety and comparative efficacy of the CVI988 vaccine strain.World's Poultry Scince Assoc,1992,1:315-319.
3Bogdan C.The function of typeⅠinterferons in anti microbiali mmunity. Curr Opin I mmunol I mmunol . 2000
4Belardelli F,Ferrantini M,Proietti E,et al.Interferon-alpha in tumor immunity and immunotherapy. Cytokine and Growth Factor Reviews . 2002
5Cooksley W G.Treatment with interferons (including pegylated interferons) in patients with hepatitis B. Seminars in Liver Disease . 2004
6Yashiro K,Lowenthal JW,O’Neil TE, et al.High-level production of recombinant chicken interferon-γby Brevibacillus choshinensis. Protein Expression and Purification . 2001
7Pawlotsky J M.The nature of interferon-alpha resistance in hepatitis C virus infection. Current Opinion Infectious Diseases . 2003
